Antihyperlipidemic & hypocholesterolemic Fas

A cell-permeable, potent inhibitor of FABP4 (Ki is = 250 and 350 nM, respectively) reduces atherosclerosis in mice lacking ApoE and protects against the development of insulin resistance associated with genetic or diet-induced obesity in mice.

A cell-permeable, potent inhibitor of FABP4 (Ki is = 250 and 350 nM, respectively) reduces atherosclerosis in mice lacking ApoE and protects against the development of insulin resistance associated with genetic or diet-induced obesity in mice.

This kit contains all chemicals required for the analysis of: Edible fats Fats and cholesterol in blood For the separations with kit F2, the materials kit TLC micro-set M is prerequisite.

Biochem/physiol Actions F1394 is an orally available, potent and selective Acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor that reduces plaque foam cell formation without inflammatory or toxic effects.

Biochem/physiol Actions F1394 is an orally available, potent and selective Acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor that reduces plaque foam cell formation without inflammatory or toxic effects.

Mouse anti Human FABP4 Antibody, Monoclonal (C12), could be used for WB, IHC and so on. Application WB: 0.01-2 µg/mL IHC: 5-20 μg/mL Protein Function Lipid transport protein in adipocytes. Binds both long chain fatty acids and retinoic acid.

Mouse anti Human FABP4 Antibody, Monoclonal (C12), could be used for WB, IHC and so on. Application WB: 0.01-2 µg/mL IHC: 5-20 μg/mL Protein Function Lipid transport protein in adipocytes. Binds both long chain fatty acids and retinoic acid.

Mouse anti Human FABP4 Antibody, Monoclonal (C12), could be used for WB, IHC and so on. Application WB: 0.01-2 µg/mL IHC: 5-20 μg/mL Protein Function Lipid transport protein in adipocytes. Binds both long chain fatty acids and retinoic acid.

Mouse anti Human FABP4 Antibody, Monoclonal (C12), could be used for WB, IHC and so on. Application WB: 0.01-2 µg/mL IHC: 5-20 μg/mL Protein Function Lipid transport protein in adipocytes. Binds both long chain fatty acids and retinoic acid.

Application Fasnall benzenesulfonate salt has been used as a fatty acid synthase inhibitor to test its effect on hypoxic U87 MG cells in cell viability assay and lipid droplet formation assay. Biochem/physiol Actions Fasnall is a fatty acid

FGH10019 is a novel sterol regulatory element-binding protein ( SREBP ) inhibitor with IC 50 of 1 μM.In VitroTreatment of the CHO-K1 cells with analog FGH10019 decreases the percentage of the mature form of SREBP-2 (68 kDa) at lower concentrations

FGH10019 is a novel sterol regulatory element-binding protein ( SREBP ) inhibitor with IC 50 of 1 μM.In VitroTreatment of the CHO-K1 cells with analog FGH10019 decreases the percentage of the mature form of SREBP-2 (68 kDa) at lower concentrations